PBI-4050 reduces pulmonary hypertension, lung fibrosis, and right ventricular dysfunction in heart failure. [electronic resource]
Producer: 20200825Description: 171-182 p. digitalISSN:- 1755-3245
- Acetates -- pharmacology
- Animals
- Cells, Cultured
- Disease Models, Animal
- Endothelin-1 -- metabolism
- Extracellular Signal-Regulated MAP Kinases -- metabolism
- Fibroblasts -- drug effects
- Fibrosis
- Heart Failure -- complications
- Heart Ventricles -- drug effects
- Humans
- Hypertension, Pulmonary -- etiology
- Hypertrophy, Right Ventricular -- etiology
- Interleukin-6 -- metabolism
- Lung -- drug effects
- Male
- Phosphorylation
- Pulmonary Fibrosis -- etiology
- Rats, Wistar
- Receptors, G-Protein-Coupled -- metabolism
- Signal Transduction
- Transforming Growth Factor beta -- metabolism
- Ventricular Dysfunction, Right -- etiology
- Ventricular Function, Right -- drug effects
- Ventricular Remodeling -- drug effects
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.